MIR31HG has been associated with unfavorable prognosis in gastric cancer [95], lung adenocarcinoma [96], head and neck squamous cell carcinoma [97,98], colorectal cancer [99], and non-small cell lung carcinoma [100]. Here, MIR31HG is linked to gastric cancer.